Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 2 (2006), Issue 12 (December)

1. QSPRs on photodegradation half-lives of atmospheric chlorinated polycyclic aromatic hydrocarbons associated with particulates.
   Ecotoxicol Environ Saf, 66(2): 272-7. [Abstract] [Full-text]
2. Rational design of a dual-mode optical and chemical prodrug.
   Pharm Res, 24(1): 194-200. [Abstract] [Full-text]
3. Raman mapping of low-content API pharmaceutical formulations. I. Mapping of Alprazolam in Alprazolam/Xanax tablets.
   Pharm Res, 24(1): 58-65. [Abstract] [Full-text]
4. Synthetic antibodies as therapeutics.
   Expert Opin Biol Ther, 7(1): 73-87. [Abstract] [Full-text]
5. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
   Adv Cancer Res, 96: 269-98. [Abstract] [Full-text]
6. Practices and pitfalls of mouse cancer models in drug discovery.
   Adv Cancer Res, 96: 191-212. [Abstract] [Full-text]
7. Cancer cell-based genomic and small molecule screens.
   Adv Cancer Res, 96: 145-73. [Abstract] [Full-text]
8. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
   Anticancer Drugs, 18(2): 111-26. [Abstract] [Full-text]
9. Alternative drug formulations of docetaxel: a review.
   Anticancer Drugs, 18(2): 95-103. [Abstract] [Full-text]
10. Integrated siRNA design based on surveying of features associated with high RNAi effectiveness.
    BMC Bioinformatics, 7: 516. [Abstract] [Full-text]
11. Production of isoprenoid pharmaceuticals by engineered microbes.
    Nat Chem Biol, 2(12): 674-81. [Abstract] [Full-text]
12. Pharmacogenetics of asthma.
    Chest, 130(6): 1873-8. [Abstract] [Full-text]
13. Herbal medicine: women's views, knowledge and interaction with doctors: a qualitative study.
    BMC Complement Altern Med, 6: 40. [Abstract] [Full-text]
14. American Board of Clinical Pharmacology fellowship training and certification in clinical pharmacology: educational value and future needs for the discipline.
    Clin Pharmacol Ther, 81(1): 134-7. [Abstract] [Full-text]
15. Drug development and the FDA's Critical Path Initiative.
    Clin Pharmacol Ther, 81(1): 129-33. [Abstract] [Full-text]
16. The ethical implications of stratifying by race in pharmacogenomics.
    Clin Pharmacol Ther, 81(1): 122-5. [Abstract] [Full-text]
17. Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy.
    Clin Pharmacol Ther, 81(1): 99-103. [Abstract] [Full-text]
18. In silico drug discovery: solving the "target-rich and lead-poor" imbalance using the genome-to-drug-lead paradigm.
    Clin Pharmacol Ther, 81(1): 30-4. [Abstract] [Full-text]
19. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Clin Pharmacol Ther, 81(1): 21-4. [Abstract] [Full-text]
20. Support vector machine based training of multilayer feedforward neural networks as optimized by particle swarm algorithm: application in QSAR studies of bioactivity of organic compounds.
    J Comput Chem, 28(2): 519-27. [Abstract] [Full-text]
21. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase.
    Org Lett, 9(1): 9-12. [Abstract] [Full-text]
22. Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
    J Clin Oncol, 25(1): 32-42. [Abstract] [Full-text]

© 2005-2008 Pharmacology Research Today. All Rights Reserved.